La ricerca è una priorità per SIFaCT e la pubblicazione del paper su una rivista scientifica di livello internazionale è il risultato finale e tangibile del lavoro svolto. Di seguito le pubblicazioni vengono suddivise secondo diversi criteri per facilitare la selezione dell’articolo di interesse prodotto dalla società scientifica.
Nel riquadro a destra puoi selezionare i seguenti 4 filtri: Anno di pubblicazione – Primo autore – Impact factor – Topic
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave.
Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe.
SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces.
Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available.
The Restricted Mean Survival Time as a Tool for Ranking Comparative Outcomes in a Narrative Review that Evaluates a Network of Randomized Trials: An Example Based on PCSK9 Inhibitors
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies
WEBINAR – Dalla genetica alle terapie personalizzate nelle malattie neurodegenerative: approfondimenti su Sclerosi Multipla e Atrofia Muscolare Spinale
CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma